NEW YORK (GenomeWeb News) – Genomatix today announced that it has entered into a cooperative research and development agreement with the Uniformed Service University of the Health Sciences and the Henry M. Jackson Foundation for the Advancement of Military Medicine to extend a collaboration aimed at prostate cancer.